Ranbaxy Laboratories (Delisted) share news and announcements
BSE: 500359
Last traded ₹859.80 on 1 Apr 2015
Delisted on 30 Mar 2016.
Ranbaxy Laboratories share news and announcements
790 announcements, routine notices left out, newest first. Page 7 of 16.
Aug 2012
Jul 2012
11 Jul · Business
ESOPs Allotment Committee of Directors vide Resolution by Circulation passed on July 11, 2012, allotted 152,361 Equity Shares on exercise of stock options under the Employees Stock Option Scheme(s) of the Company. The paid-up Equity Share Capital of the Company post allotment is 422,264,949 Equity Shares of Rs. 5 each aggregating Rs. 2,111,324,745/-.11 Jul · Allotment of Equity Shares
ESOPs Allotment Committee of Directors vide Resolution by Circulation passed on July 11, 2012, allotted 152,361 Equity Shares on exercise ....6 Jul · Results
Meeting of the Board of Directors of the Company will be held on August 09, 2012, inter-alia, to consider and approve Standalone and Consolidated ....6 Jul · Board meeting
Inter-alia to consider and approve Standalone and Consolidated Unaudited Financial Results for the second quarter and half year ended June 30, 2012 as reviewed by the Statutory Auditors of the Company.
Jun 2012
May 2012
28 May · Ranbaxy Announces USFDA approval of CIP-ISOTRETINOIN NDA
10 May · Disclosure of Voting Pattern - Clause 35A
9 May · Management
Board of Directors of the Company at its meeting held on May 09, 2012, have approved the appointment of Dr. Kazunori Hirokawa, as an Additional Director. Dr. Hirokawa, M. D. Ph.D, is a member of the Board, Senior Executive Officer and Head of Corporate Strategy Division of Daiichi Sankyo Company, Limited, Japan.9 May · Board meeting
Board of Directors of the Company at its meeting held on May 09, 2012, inter alia, have approved the appointment of Dr. Kazunori Hirokawa, ....9 May · Results
Consolidated Results for the quarter ended on 31-MAR-2012 as follows: Net Sales of Rs. 369540.3 lacs for quarter ending on 31-MAR-2012 against Rs. 214302 lacs for the quarter ending on 31-MAR-2011. Net Profit / (Loss) of Rs. 124676.4 lacs for the quarter ending on 31-MAR-2012 against Rs. 30438.7 lacs for the quarter ending on 31-MAR-2011.9 May · Results
Standalone Results for the quarter ended on 31-MAR-2012 as follows: Net Sales of Rs. 181022.8 lacs for quarter ending on 31-MAR-2012 against Rs. 105644.4 lacs for the quarter ending on 31-MAR-2011. Net Profit / (Loss) of Rs. 82723.1 lacs for the quarter ending on 31-MAR-2012 against Rs. (5290.7) lacs for the quarter ending on 31-MAR-2011.
Apr 2012
19 Apr · Daiichi Sankyo and Ranbaxy to expand Hybrid Business Model in Romania
18 Apr · Business
ESOPs Allotment Committee of Directors vide Resolution by Circulation passed on April 17, 2012, allotted 80,898 Equity Shares on exercise of stock options under the Employees Stock Option Scheme(s) of the Company. The paid-up Equity Share Capital of the Company post allotment is 422,112,588 Equity Shares of Rs. 5 each aggregating Rs. 2,110,562,940/-.17 Apr · Allotment of Equity Shares
ESOPs Allotment Committee of Directors vide Resolution by Circulation passed on April 17, 2012, allotted 80,898 Equity Shares on exercise ....13 Apr · Ranbaxy adjudged Malaysian Pharmaceutical Company of the Year for 2012
11 Apr · Board meeting
Inter-alia to consider Standalone and Consolidated Unaudited Financial Results for the quarter ended March 31, 2012 as reviewed by the Statutory Auditors of the Company.11 Apr · Results
Meeting of the Board of Directors of the Company will be held on May 09, 2012, inter-alia, to consider Standalone and Consolidated Unaudited ....2 Apr · Ranbaxy’s Mohali SEZ Facility begins export of Atorvastatin to the US market
Mar 2012
31 Mar · Ranbaxy receives approval to Market RAN - ROSUVASTATIN in Canada
12 Mar · Ranbaxy opens new manufacturing facility in Morocco
Feb 2012
24 Feb · Limited Review Report
Auditors have conducted the limited review for the un-audited financial results for the quarter ended December 31,2011 A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.23 Feb · Meeting
Board of Directors at its meeting held on February 23, 2012 has decided to (1) convene the Annual General Meeting (AGM) of the Company on Tuesday, May 8, 2012. Share transfer books for the purpose of AGM will remain closed from April 28, 2012 to May 8, 2012 (both days inclusive).23 Feb · Audit Reports for Dec 31, 2011
23 Feb · Board meeting
Board of Directors of the Company at its meeting held on February 23, 2012 has decided to : (1) Re-appoint Mr. Arun Sawhney as CEO & Managing Director of the Company for a period of 5 years effective January 01, 2012, subject to requisite approvals.